Suchergebnisse - "Yusuf, Buhari"

PubPharm (11)

1

MtrAB two-component system is crucial for the intrinsic resistance and virulence ofMycobacterium abscessus

enthalten in: bioRxiv.org | 2024

von Zhang, J. | Ju, Y. | Li, L. | +10

2

High-throughput Screening of Compounds against Autoluminescent NonreplicatingMycobacterium tuberculosisunder Diverse Conditions

enthalten in: bioRxiv.org | 2024

von Tian, X. | Ma, W. | Yusuf, B. | +6

3

Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents : Mechanistic Studies and Therapeutic Potential

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2023

von Frolova, S. | Vatlin, A. | Maslov, D. | +14

4

Distribution of common and rare drug resistance patterns in Mycobacterium tuberculosis clinical isolates revealed by GenoType MTBDRplus and MTBDRsl assay

enthalten in: Journal of thoracic disease | 2023

von Khan, Z. | Zhu, Y. | Guan, P. | +14

5

Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis

enthalten in: Journal of medicinal chemistry | 2023

von Li, C. | Tian, X. | Huang, Z. | +11

6

Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis

enthalten in: Frontiers in medicine | 2023

von Islam, M. | Alam, M. | Liu, Z. | +16

7

Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus

enthalten in: Microbiology spectrum | 2022

von Wang, S. | Cai, X. | Yu, W. | +20

8

Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001

enthalten in: Frontiers in cellular and infection microbiology | 2022

von Alam, M. | Guan, P. | Zhu, Y. | +15

9

A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line tuberculosis regimen

enthalten in: bioRxiv.org | 2021

von Chiwala, G. | Liu, Z. | Mugweru, J. | +13

10

A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2021

von Chiwala, G. | Liu, Z. | Mugweru, J. | +13